Sources: Neuralink co-founder Paul Merolla left the company in recent weeks, the latest in a string of departures at the Elon Musk-backed brain implant startup
Rachael Levy / Reuters :
Context & Ripple Effects
Neuralink has been losing founders since before this departure: President and co-founder Max Hodak tweeted his exit in May 2021, and Paul Merolla's quiet departure makes him the second of the company's founding team to go. The startup was launched by Elon Musk in 2017 to implant electrodes for a 'direct cortical interface,' and the exits have accumulated alongside signs of technical strain.
The timing matters because the pressure on Neuralink is visible from both sides: sources later reported Musk approached rival developer Synchron about an investment out of frustration with Neuralink's progress, and the company disclosed that tiny wires in its first patient's brain had pulled out of position — an issue Reuters reported it had known about for years.
First-order effects
- Neuralink loses another member of its founding technical bench, deepening a leadership drain that began with Hodak's 2021 exit and leaving fewer original architects of the implant program inside the company.
Second-order effects
- Musk's outreach to Synchron, driven by frustration with Neuralink's pace, shows the departures pushing him to hedge across brain-computer interface developers rather than rely solely on his own startup.
Third-order effects
- If founder attrition and hardware setbacks keep compounding, capital and talent in brain-computer interfaces shift toward rivals — a pattern later visible when Sam Altman's Merge Labs hired neural-imaging researcher Mikhail Shapiro — fragmenting what Musk once framed as a single-company mission.
The trend: Brain-computer interface development is consolidating around competing well-funded camps as Neuralink's founder exodus pushes even Musk to diversify beyond his own startup.